0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Nuclear Medicine Imaging Agents - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: December 2024
|
Report Code: QYRE-Auto-18C15007
Home | Market Reports | Health| Medical Devices & Equipment
Global Nuclear Medicine Imaging Agents Market Research Report 2023
BUY CHAPTERS

Nuclear Medicine Imaging Agents - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-18C15007
Report
December 2024
Pages:131
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Nuclear Medicine Imaging Agents - Market

The global market for Nuclear Medicine Imaging Agents was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Nuclear Medicine Imaging Agents was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nuclear Medicine Imaging Agents was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Nuclear Medicine Imaging Agents was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Nuclear Medicine Imaging Agents include GE HealthCare, Bracco Diagnostic, Guerbet, Mallinckrodt, Lantheus, Yantai Dongcheng, Foshan Rui Diao Pharmaceutical, Cardinal Health and Blue Earth Diagnostics, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine Imaging Agents, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Nuclear Medicine Imaging Agents by region & country, by Type, and by Application.
The Nuclear Medicine Imaging Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine Imaging Agents.
Market Segmentation

Scope of Nuclear Medicine Imaging Agents - Market Report

Report Metric Details
Report Name Nuclear Medicine Imaging Agents - Market
Segment by Type:
  • Fluorine 18 Labeling
  • Carbon 11 Labeling
  • Nitrogen 13 Labeling
  • Oxygen 15 Labeling
  • Technetium 99 Labeling
  • Others
Segment by Application
  • Early Diagnosis
  • Clinical Stage
  • Treatment Evaluation
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GE HealthCare, Bracco Diagnostic, Guerbet, Mallinckrodt, Lantheus, Yantai Dongcheng, Foshan Rui Diao Pharmaceutical, Cardinal Health, Blue Earth Diagnostics, Bayer AG, Abx Advanced Biochemical, Eli Lilly and Company, Jubilant Pharma Limited, Navidea
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Nuclear Medicine Imaging Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Nuclear Medicine Imaging Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Nuclear Medicine Imaging Agents in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Nuclear Medicine Imaging Agents - Market report?

Ans: The main players in the Nuclear Medicine Imaging Agents - Market are GE HealthCare, Bracco Diagnostic, Guerbet, Mallinckrodt, Lantheus, Yantai Dongcheng, Foshan Rui Diao Pharmaceutical, Cardinal Health, Blue Earth Diagnostics, Bayer AG, Abx Advanced Biochemical, Eli Lilly and Company, Jubilant Pharma Limited, Navidea

What are the Application segmentation covered in the Nuclear Medicine Imaging Agents - Market report?

Ans: The Applications covered in the Nuclear Medicine Imaging Agents - Market report are Early Diagnosis, Clinical Stage, Treatment Evaluation

What are the Type segmentation covered in the Nuclear Medicine Imaging Agents - Market report?

Ans: The Types covered in the Nuclear Medicine Imaging Agents - Market report are Fluorine 18 Labeling, Carbon 11 Labeling, Nitrogen 13 Labeling, Oxygen 15 Labeling, Technetium 99 Labeling, Others

1 Market Overview
1.1 Nuclear Medicine Imaging Agents Product Introduction
1.2 Global Nuclear Medicine Imaging Agents Market Size Forecast
1.2.1 Global Nuclear Medicine Imaging Agents Sales Value (2019-2030)
1.2.2 Global Nuclear Medicine Imaging Agents Sales Volume (2019-2030)
1.2.3 Global Nuclear Medicine Imaging Agents Sales Price (2019-2030)
1.3 Nuclear Medicine Imaging Agents Market Trends & Drivers
1.3.1 Nuclear Medicine Imaging Agents Industry Trends
1.3.2 Nuclear Medicine Imaging Agents Market Drivers & Opportunity
1.3.3 Nuclear Medicine Imaging Agents Market Challenges
1.3.4 Nuclear Medicine Imaging Agents Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Nuclear Medicine Imaging Agents Players Revenue Ranking (2023)
2.2 Global Nuclear Medicine Imaging Agents Revenue by Company (2019-2024)
2.3 Global Nuclear Medicine Imaging Agents Players Sales Volume Ranking (2023)
2.4 Global Nuclear Medicine Imaging Agents Sales Volume by Company Players (2019-2024)
2.5 Global Nuclear Medicine Imaging Agents Average Price by Company (2019-2024)
2.6 Key Manufacturers Nuclear Medicine Imaging Agents Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Nuclear Medicine Imaging Agents Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Nuclear Medicine Imaging Agents
2.9 Nuclear Medicine Imaging Agents Market Competitive Analysis
2.9.1 Nuclear Medicine Imaging Agents Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Nuclear Medicine Imaging Agents Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine Imaging Agents as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Fluorine 18 Labeling
3.1.2 Carbon 11 Labeling
3.1.3 Nitrogen 13 Labeling
3.1.4 Oxygen 15 Labeling
3.1.5 Technetium 99 Labeling
3.1.6 Others
3.2 Global Nuclear Medicine Imaging Agents Sales Value by Type
3.2.1 Global Nuclear Medicine Imaging Agents Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Nuclear Medicine Imaging Agents Sales Value, by Type (2019-2030)
3.2.3 Global Nuclear Medicine Imaging Agents Sales Value, by Type (%) (2019-2030)
3.3 Global Nuclear Medicine Imaging Agents Sales Volume by Type
3.3.1 Global Nuclear Medicine Imaging Agents Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Nuclear Medicine Imaging Agents Sales Volume, by Type (2019-2030)
3.3.3 Global Nuclear Medicine Imaging Agents Sales Volume, by Type (%) (2019-2030)
3.4 Global Nuclear Medicine Imaging Agents Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Early Diagnosis
4.1.2 Clinical Stage
4.1.3 Treatment Evaluation
4.2 Global Nuclear Medicine Imaging Agents Sales Value by Application
4.2.1 Global Nuclear Medicine Imaging Agents Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Nuclear Medicine Imaging Agents Sales Value, by Application (2019-2030)
4.2.3 Global Nuclear Medicine Imaging Agents Sales Value, by Application (%) (2019-2030)
4.3 Global Nuclear Medicine Imaging Agents Sales Volume by Application
4.3.1 Global Nuclear Medicine Imaging Agents Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Nuclear Medicine Imaging Agents Sales Volume, by Application (2019-2030)
4.3.3 Global Nuclear Medicine Imaging Agents Sales Volume, by Application (%) (2019-2030)
4.4 Global Nuclear Medicine Imaging Agents Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Nuclear Medicine Imaging Agents Sales Value by Region
5.1.1 Global Nuclear Medicine Imaging Agents Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Nuclear Medicine Imaging Agents Sales Value by Region (2019-2024)
5.1.3 Global Nuclear Medicine Imaging Agents Sales Value by Region (2025-2030)
5.1.4 Global Nuclear Medicine Imaging Agents Sales Value by Region (%), (2019-2030)
5.2 Global Nuclear Medicine Imaging Agents Sales Volume by Region
5.2.1 Global Nuclear Medicine Imaging Agents Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Nuclear Medicine Imaging Agents Sales Volume by Region (2019-2024)
5.2.3 Global Nuclear Medicine Imaging Agents Sales Volume by Region (2025-2030)
5.2.4 Global Nuclear Medicine Imaging Agents Sales Volume by Region (%), (2019-2030)
5.3 Global Nuclear Medicine Imaging Agents Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Nuclear Medicine Imaging Agents Sales Value, 2019-2030
5.4.2 North America Nuclear Medicine Imaging Agents Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Nuclear Medicine Imaging Agents Sales Value, 2019-2030
5.5.2 Europe Nuclear Medicine Imaging Agents Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Nuclear Medicine Imaging Agents Sales Value, 2019-2030
5.6.2 Asia Pacific Nuclear Medicine Imaging Agents Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Nuclear Medicine Imaging Agents Sales Value, 2019-2030
5.7.2 South America Nuclear Medicine Imaging Agents Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Nuclear Medicine Imaging Agents Sales Value, 2019-2030
5.8.2 Middle East & Africa Nuclear Medicine Imaging Agents Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Nuclear Medicine Imaging Agents Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Nuclear Medicine Imaging Agents Sales Value
6.2.1 Key Countries/Regions Nuclear Medicine Imaging Agents Sales Value, 2019-2030
6.2.2 Key Countries/Regions Nuclear Medicine Imaging Agents Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Nuclear Medicine Imaging Agents Sales Value, 2019-2030
6.3.2 United States Nuclear Medicine Imaging Agents Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Nuclear Medicine Imaging Agents Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Nuclear Medicine Imaging Agents Sales Value, 2019-2030
6.4.2 Europe Nuclear Medicine Imaging Agents Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Nuclear Medicine Imaging Agents Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Nuclear Medicine Imaging Agents Sales Value, 2019-2030
6.5.2 China Nuclear Medicine Imaging Agents Sales Value by Type (%), 2023 VS 2030
6.5.3 China Nuclear Medicine Imaging Agents Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Nuclear Medicine Imaging Agents Sales Value, 2019-2030
6.6.2 Japan Nuclear Medicine Imaging Agents Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Nuclear Medicine Imaging Agents Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Nuclear Medicine Imaging Agents Sales Value, 2019-2030
6.7.2 South Korea Nuclear Medicine Imaging Agents Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Nuclear Medicine Imaging Agents Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Nuclear Medicine Imaging Agents Sales Value, 2019-2030
6.8.2 Southeast Asia Nuclear Medicine Imaging Agents Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Nuclear Medicine Imaging Agents Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Nuclear Medicine Imaging Agents Sales Value, 2019-2030
6.9.2 India Nuclear Medicine Imaging Agents Sales Value by Type (%), 2023 VS 2030
6.9.3 India Nuclear Medicine Imaging Agents Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 GE HealthCare
7.1.1 GE HealthCare Company Information
7.1.2 GE HealthCare Introduction and Business Overview
7.1.3 GE HealthCare Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2019-2024)
7.1.4 GE HealthCare Nuclear Medicine Imaging Agents Product Offerings
7.1.5 GE HealthCare Recent Development
7.2 Bracco Diagnostic
7.2.1 Bracco Diagnostic Company Information
7.2.2 Bracco Diagnostic Introduction and Business Overview
7.2.3 Bracco Diagnostic Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Bracco Diagnostic Nuclear Medicine Imaging Agents Product Offerings
7.2.5 Bracco Diagnostic Recent Development
7.3 Guerbet
7.3.1 Guerbet Company Information
7.3.2 Guerbet Introduction and Business Overview
7.3.3 Guerbet Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Guerbet Nuclear Medicine Imaging Agents Product Offerings
7.3.5 Guerbet Recent Development
7.4 Mallinckrodt
7.4.1 Mallinckrodt Company Information
7.4.2 Mallinckrodt Introduction and Business Overview
7.4.3 Mallinckrodt Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Mallinckrodt Nuclear Medicine Imaging Agents Product Offerings
7.4.5 Mallinckrodt Recent Development
7.5 Lantheus
7.5.1 Lantheus Company Information
7.5.2 Lantheus Introduction and Business Overview
7.5.3 Lantheus Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Lantheus Nuclear Medicine Imaging Agents Product Offerings
7.5.5 Lantheus Recent Development
7.6 Yantai Dongcheng
7.6.1 Yantai Dongcheng Company Information
7.6.2 Yantai Dongcheng Introduction and Business Overview
7.6.3 Yantai Dongcheng Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Yantai Dongcheng Nuclear Medicine Imaging Agents Product Offerings
7.6.5 Yantai Dongcheng Recent Development
7.7 Foshan Rui Diao Pharmaceutical
7.7.1 Foshan Rui Diao Pharmaceutical Company Information
7.7.2 Foshan Rui Diao Pharmaceutical Introduction and Business Overview
7.7.3 Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Product Offerings
7.7.5 Foshan Rui Diao Pharmaceutical Recent Development
7.8 Cardinal Health
7.8.1 Cardinal Health Company Information
7.8.2 Cardinal Health Introduction and Business Overview
7.8.3 Cardinal Health Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Cardinal Health Nuclear Medicine Imaging Agents Product Offerings
7.8.5 Cardinal Health Recent Development
7.9 Blue Earth Diagnostics
7.9.1 Blue Earth Diagnostics Company Information
7.9.2 Blue Earth Diagnostics Introduction and Business Overview
7.9.3 Blue Earth Diagnostics Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Blue Earth Diagnostics Nuclear Medicine Imaging Agents Product Offerings
7.9.5 Blue Earth Diagnostics Recent Development
7.10 Bayer AG
7.10.1 Bayer AG Company Information
7.10.2 Bayer AG Introduction and Business Overview
7.10.3 Bayer AG Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Bayer AG Nuclear Medicine Imaging Agents Product Offerings
7.10.5 Bayer AG Recent Development
7.11 Abx Advanced Biochemical
7.11.1 Abx Advanced Biochemical Company Information
7.11.2 Abx Advanced Biochemical Introduction and Business Overview
7.11.3 Abx Advanced Biochemical Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Abx Advanced Biochemical Nuclear Medicine Imaging Agents Product Offerings
7.11.5 Abx Advanced Biochemical Recent Development
7.12 Eli Lilly and Company
7.12.1 Eli Lilly and Company Company Information
7.12.2 Eli Lilly and Company Introduction and Business Overview
7.12.3 Eli Lilly and Company Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Eli Lilly and Company Nuclear Medicine Imaging Agents Product Offerings
7.12.5 Eli Lilly and Company Recent Development
7.13 Jubilant Pharma Limited
7.13.1 Jubilant Pharma Limited Company Information
7.13.2 Jubilant Pharma Limited Introduction and Business Overview
7.13.3 Jubilant Pharma Limited Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Jubilant Pharma Limited Nuclear Medicine Imaging Agents Product Offerings
7.13.5 Jubilant Pharma Limited Recent Development
7.14 Navidea
7.14.1 Navidea Company Information
7.14.2 Navidea Introduction and Business Overview
7.14.3 Navidea Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Navidea Nuclear Medicine Imaging Agents Product Offerings
7.14.5 Navidea Recent Development
8 Industry Chain Analysis
8.1 Nuclear Medicine Imaging Agents Industrial Chain
8.2 Nuclear Medicine Imaging Agents Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Nuclear Medicine Imaging Agents Sales Model
8.5.2 Sales Channel
8.5.3 Nuclear Medicine Imaging Agents Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Nuclear Medicine Imaging Agents Market Trends
    Table 2. Nuclear Medicine Imaging Agents Market Drivers & Opportunity
    Table 3. Nuclear Medicine Imaging Agents Market Challenges
    Table 4. Nuclear Medicine Imaging Agents Market Restraints
    Table 5. Global Nuclear Medicine Imaging Agents Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Nuclear Medicine Imaging Agents Revenue Market Share by Company (2019-2024)
    Table 7. Global Nuclear Medicine Imaging Agents Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Nuclear Medicine Imaging Agents Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Nuclear Medicine Imaging Agents Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Nuclear Medicine Imaging Agents Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Nuclear Medicine Imaging Agents Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Nuclear Medicine Imaging Agents
    Table 13. Global Nuclear Medicine Imaging Agents Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine Imaging Agents as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Nuclear Medicine Imaging Agents Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Nuclear Medicine Imaging Agents Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Nuclear Medicine Imaging Agents Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Nuclear Medicine Imaging Agents Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Nuclear Medicine Imaging Agents Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Nuclear Medicine Imaging Agents Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Nuclear Medicine Imaging Agents Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Nuclear Medicine Imaging Agents Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Nuclear Medicine Imaging Agents Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Nuclear Medicine Imaging Agents Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Nuclear Medicine Imaging Agents Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Nuclear Medicine Imaging Agents Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Nuclear Medicine Imaging Agents Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Nuclear Medicine Imaging Agents Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Nuclear Medicine Imaging Agents Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Nuclear Medicine Imaging Agents Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Nuclear Medicine Imaging Agents Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Nuclear Medicine Imaging Agents Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Nuclear Medicine Imaging Agents Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Nuclear Medicine Imaging Agents Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Nuclear Medicine Imaging Agents Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Nuclear Medicine Imaging Agents Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Nuclear Medicine Imaging Agents Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Nuclear Medicine Imaging Agents Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Nuclear Medicine Imaging Agents Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Nuclear Medicine Imaging Agents Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Nuclear Medicine Imaging Agents Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Nuclear Medicine Imaging Agents Sales Value by Region (2019-2024) & (%)
    Table 44. Global Nuclear Medicine Imaging Agents Sales Value by Region (2025-2030) & (%)
    Table 45. Global Nuclear Medicine Imaging Agents Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Nuclear Medicine Imaging Agents Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Nuclear Medicine Imaging Agents Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Nuclear Medicine Imaging Agents Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Nuclear Medicine Imaging Agents Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Nuclear Medicine Imaging Agents Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Nuclear Medicine Imaging Agents Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Nuclear Medicine Imaging Agents Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Nuclear Medicine Imaging Agents Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Nuclear Medicine Imaging Agents Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Nuclear Medicine Imaging Agents Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Nuclear Medicine Imaging Agents Sales Volume, (2025-2030) & (K Units)
    Table 57. GE HealthCare Company Information
    Table 58. GE HealthCare Introduction and Business Overview
    Table 59. GE HealthCare Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. GE HealthCare Nuclear Medicine Imaging Agents Product Offerings
    Table 61. GE HealthCare Recent Development
    Table 62. Bracco Diagnostic Company Information
    Table 63. Bracco Diagnostic Introduction and Business Overview
    Table 64. Bracco Diagnostic Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Bracco Diagnostic Nuclear Medicine Imaging Agents Product Offerings
    Table 66. Bracco Diagnostic Recent Development
    Table 67. Guerbet Company Information
    Table 68. Guerbet Introduction and Business Overview
    Table 69. Guerbet Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Guerbet Nuclear Medicine Imaging Agents Product Offerings
    Table 71. Guerbet Recent Development
    Table 72. Mallinckrodt Company Information
    Table 73. Mallinckrodt Introduction and Business Overview
    Table 74. Mallinckrodt Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Mallinckrodt Nuclear Medicine Imaging Agents Product Offerings
    Table 76. Mallinckrodt Recent Development
    Table 77. Lantheus Company Information
    Table 78. Lantheus Introduction and Business Overview
    Table 79. Lantheus Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Lantheus Nuclear Medicine Imaging Agents Product Offerings
    Table 81. Lantheus Recent Development
    Table 82. Yantai Dongcheng Company Information
    Table 83. Yantai Dongcheng Introduction and Business Overview
    Table 84. Yantai Dongcheng Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Yantai Dongcheng Nuclear Medicine Imaging Agents Product Offerings
    Table 86. Yantai Dongcheng Recent Development
    Table 87. Foshan Rui Diao Pharmaceutical Company Information
    Table 88. Foshan Rui Diao Pharmaceutical Introduction and Business Overview
    Table 89. Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Product Offerings
    Table 91. Foshan Rui Diao Pharmaceutical Recent Development
    Table 92. Cardinal Health Company Information
    Table 93. Cardinal Health Introduction and Business Overview
    Table 94. Cardinal Health Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Cardinal Health Nuclear Medicine Imaging Agents Product Offerings
    Table 96. Cardinal Health Recent Development
    Table 97. Blue Earth Diagnostics Company Information
    Table 98. Blue Earth Diagnostics Introduction and Business Overview
    Table 99. Blue Earth Diagnostics Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Blue Earth Diagnostics Nuclear Medicine Imaging Agents Product Offerings
    Table 101. Blue Earth Diagnostics Recent Development
    Table 102. Bayer AG Company Information
    Table 103. Bayer AG Introduction and Business Overview
    Table 104. Bayer AG Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Bayer AG Nuclear Medicine Imaging Agents Product Offerings
    Table 106. Bayer AG Recent Development
    Table 107. Abx Advanced Biochemical Company Information
    Table 108. Abx Advanced Biochemical Introduction and Business Overview
    Table 109. Abx Advanced Biochemical Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Abx Advanced Biochemical Nuclear Medicine Imaging Agents Product Offerings
    Table 111. Abx Advanced Biochemical Recent Development
    Table 112. Eli Lilly and Company Company Information
    Table 113. Eli Lilly and Company Introduction and Business Overview
    Table 114. Eli Lilly and Company Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Eli Lilly and Company Nuclear Medicine Imaging Agents Product Offerings
    Table 116. Eli Lilly and Company Recent Development
    Table 117. Jubilant Pharma Limited Company Information
    Table 118. Jubilant Pharma Limited Introduction and Business Overview
    Table 119. Jubilant Pharma Limited Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Jubilant Pharma Limited Nuclear Medicine Imaging Agents Product Offerings
    Table 121. Jubilant Pharma Limited Recent Development
    Table 122. Navidea Company Information
    Table 123. Navidea Introduction and Business Overview
    Table 124. Navidea Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Navidea Nuclear Medicine Imaging Agents Product Offerings
    Table 126. Navidea Recent Development
    Table 127. Key Raw Materials Lists
    Table 128. Raw Materials Key Suppliers Lists
    Table 129. Nuclear Medicine Imaging Agents Downstream Customers
    Table 130. Nuclear Medicine Imaging Agents Distributors List
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. Nuclear Medicine Imaging Agents Product Picture
    Figure 2. Global Nuclear Medicine Imaging Agents Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Nuclear Medicine Imaging Agents Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Nuclear Medicine Imaging Agents Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Nuclear Medicine Imaging Agents Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Nuclear Medicine Imaging Agents Report Years Considered
    Figure 7. Global Nuclear Medicine Imaging Agents Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Nuclear Medicine Imaging Agents Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Nuclear Medicine Imaging Agents Revenue in 2023
    Figure 10. Nuclear Medicine Imaging Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Fluorine 18 Labeling Picture
    Figure 12. Carbon 11 Labeling Picture
    Figure 13. Nitrogen 13 Labeling Picture
    Figure 14. Oxygen 15 Labeling Picture
    Figure 15. Technetium 99 Labeling Picture
    Figure 16. Others Picture
    Figure 17. Global Nuclear Medicine Imaging Agents Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Nuclear Medicine Imaging Agents Sales Value Market Share by Type, 2023 & 2030
    Figure 19. Global Nuclear Medicine Imaging Agents Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 20. Global Nuclear Medicine Imaging Agents Sales Volume Market Share by Type, 2023 & 2030
    Figure 21. Global Nuclear Medicine Imaging Agents Price by Type (2019-2030) & (US$/Unit)
    Figure 22. Product Picture of Early Diagnosis
    Figure 23. Product Picture of Clinical Stage
    Figure 24. Product Picture of Treatment Evaluation
    Figure 25. Global Nuclear Medicine Imaging Agents Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 26. Global Nuclear Medicine Imaging Agents Sales Value Market Share by Application, 2023 & 2030
    Figure 27. Global Nuclear Medicine Imaging Agents Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 28. Global Nuclear Medicine Imaging Agents Sales Volume Market Share by Application, 2023 & 2030
    Figure 29. Global Nuclear Medicine Imaging Agents Price by Application (2019-2030) & (US$/Unit)
    Figure 30. North America Nuclear Medicine Imaging Agents Sales Value (2019-2030) & (US$ Million)
    Figure 31. North America Nuclear Medicine Imaging Agents Sales Value by Country (%), 2023 VS 2030
    Figure 32. Europe Nuclear Medicine Imaging Agents Sales Value (2019-2030) & (US$ Million)
    Figure 33. Europe Nuclear Medicine Imaging Agents Sales Value by Country (%), 2023 VS 2030
    Figure 34. Asia Pacific Nuclear Medicine Imaging Agents Sales Value (2019-2030) & (US$ Million)
    Figure 35. Asia Pacific Nuclear Medicine Imaging Agents Sales Value by Country (%), 2023 VS 2030
    Figure 36. South America Nuclear Medicine Imaging Agents Sales Value (2019-2030) & (US$ Million)
    Figure 37. South America Nuclear Medicine Imaging Agents Sales Value by Country (%), 2023 VS 2030
    Figure 38. Middle East & Africa Nuclear Medicine Imaging Agents Sales Value (2019-2030) & (US$ Million)
    Figure 39. Middle East & Africa Nuclear Medicine Imaging Agents Sales Value by Country (%), 2023 VS 2030
    Figure 40. Key Countries/Regions Nuclear Medicine Imaging Agents Sales Value (%), (2019-2030)
    Figure 41. Key Countries/Regions Nuclear Medicine Imaging Agents Sales Volume (%), (2019-2030)
    Figure 42. United States Nuclear Medicine Imaging Agents Sales Value, (2019-2030) & (US$ Million)
    Figure 43. United States Nuclear Medicine Imaging Agents Sales Value by Type (%), 2023 VS 2030
    Figure 44. United States Nuclear Medicine Imaging Agents Sales Value by Application (%), 2023 VS 2030
    Figure 45. Europe Nuclear Medicine Imaging Agents Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Europe Nuclear Medicine Imaging Agents Sales Value by Type (%), 2023 VS 2030
    Figure 47. Europe Nuclear Medicine Imaging Agents Sales Value by Application (%), 2023 VS 2030
    Figure 48. China Nuclear Medicine Imaging Agents Sales Value, (2019-2030) & (US$ Million)
    Figure 49. China Nuclear Medicine Imaging Agents Sales Value by Type (%), 2023 VS 2030
    Figure 50. China Nuclear Medicine Imaging Agents Sales Value by Application (%), 2023 VS 2030
    Figure 51. Japan Nuclear Medicine Imaging Agents Sales Value, (2019-2030) & (US$ Million)
    Figure 52. Japan Nuclear Medicine Imaging Agents Sales Value by Type (%), 2023 VS 2030
    Figure 53. Japan Nuclear Medicine Imaging Agents Sales Value by Application (%), 2023 VS 2030
    Figure 54. South Korea Nuclear Medicine Imaging Agents Sales Value, (2019-2030) & (US$ Million)
    Figure 55. South Korea Nuclear Medicine Imaging Agents Sales Value by Type (%), 2023 VS 2030
    Figure 56. South Korea Nuclear Medicine Imaging Agents Sales Value by Application (%), 2023 VS 2030
    Figure 57. Southeast Asia Nuclear Medicine Imaging Agents Sales Value, (2019-2030) & (US$ Million)
    Figure 58. Southeast Asia Nuclear Medicine Imaging Agents Sales Value by Type (%), 2023 VS 2030
    Figure 59. Southeast Asia Nuclear Medicine Imaging Agents Sales Value by Application (%), 2023 VS 2030
    Figure 60. India Nuclear Medicine Imaging Agents Sales Value, (2019-2030) & (US$ Million)
    Figure 61. India Nuclear Medicine Imaging Agents Sales Value by Type (%), 2023 VS 2030
    Figure 62. India Nuclear Medicine Imaging Agents Sales Value by Application (%), 2023 VS 2030
    Figure 63. Nuclear Medicine Imaging Agents Industrial Chain
    Figure 64. Nuclear Medicine Imaging Agents Manufacturing Cost Structure
    Figure 65. Channels of Distribution (Direct Sales, and Distribution)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Bedside Monitoring Systems Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10D12702
Thu Feb 20 00:00:00 UTC 2025

Add to Cart

Global Liquid Embolic System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24A10199
Thu Feb 20 00:00:00 UTC 2025

Add to Cart

Global Podiatry Micromotor Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11Z13155
Thu Feb 20 00:00:00 UTC 2025

Add to Cart

Global Medical High Temperature Sterilizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22G10449
Thu Feb 20 00:00:00 UTC 2025

Add to Cart